Dr. Tsui’s Medical Weight Loss Program

At Coronado Health Direct Primary Care, we are proud to offer semaglutide in Las Vegas and surrounding areas. Semaglutide is a cutting-edge, FDA-approved medication that supports chronic weight management in adults with obesity or those with weight-related conditions and health risks. Semaglutide is a GLP-1 receptor agonist that’s similar to incretin, a naturally-occurring hormone that controls your appetite. As such, the semaglutide medication can control your appetite and prevent hunger pangs, thus supporting your weight loss goals.

Semaglutide is a one-of-a-kind drug only meant for individuals who are overweight or obese, i.e., those with a BMI of 27 or more and a weight-related condition, such as diabetes, or those with a BMI of 30 or more. Please note that this medication isn’t an alternative to exercise and a healthy diet—it can only support other weight loss efforts, such as exercise, a low-calorie diet, and behavior changes.

Tirzepatide serves as a pharmaceutical-grade weight loss supplement renowned for its appetite-suppressing effects, facilitating a sensation of fullness quicker and for extended durations. Specifically engineered to target the GLP-1 receptor situated in the gastrointestinal tract, Tirzepatide orchestrates signals to the brain, prompting a cessation of hunger cues. By leveraging this precise mechanism, Tirzepatide effectively induces feelings of satiety, alleviating hunger pangs. Moreover, it exhibits the capability to inhibit the release of ghrelin, a hormone associated with hunger, thereby facilitating adherence to low-calorie dietary regimens.

In addition to killing your appetite, our Tirzepatide in Las Vegas can also slow down the digestive processes within your stomach. This medication makes your stomach empty out slower, so you continue feeling sated long after your meals, preventing you from snacking between meals. Studies have shown that consistent use of Tirzepatide, in combination with a healthy diet and regular exercise, can lead to a 5% to 22.5% reduction in total body weight.

Liraglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is used primarily for the treatment of type 2 diabetes mellitus. Liraglutide works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels by stimulating insulin secretion, slowing down gastric emptying, and reducing appetite.

In addition to its use in diabetes management, liraglutide has also been approved for weight management in certain individuals who have obesity or who are overweight and have weight-related complications. When used for weight management, it is administered at a higher dose than when used for diabetes treatment.

Liraglutide is typically administered via subcutaneous injection.

Phentermine is a medication primarily used for short-term weight loss in individuals who are overweight or obese. It is classified as a sympathomimetic amine, which means it works by stimulating the release of certain neurotransmitters in the brain, specifically norepinephrine, to suppress appetite.

Phentermine is typically prescribed as part of a comprehensive weight loss program that includes dietary changes, exercise, and behavior modification. It is intended for use in individuals who have not been able to lose weight through diet and exercise alone and who have certain risk factors related to their weight.

Because of its potential side effects and interactions with other medications, phentermine should only be used under the guidance of a healthcare professional. It is typically recommended for short-term use only, usually a few weeks to a few months. Long-term use is generally not advised due to the risk of developing tolerance and dependence.

Qsymia is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults who are overweight or obese. It is a combination medication containing two active ingredients: phentermine and topiramate extended-release.

Phentermine, as mentioned earlier, is an appetite suppressant that works by stimulating the release of certain neurotransmitters in the brain to reduce appetite and promote weight loss.

Topiramate is an anticonvulsant medication used to treat epilepsy and prevent migraines. Its exact mechanism of action in promoting weight loss is not fully understood, but it is thought to involve appetite suppression and modulation of certain neurotransmitter systems.

The combination of phentermine and topiramate in Qsymia is believed to enhance weight loss by targeting both appetite control and satiety, making it easier for individuals to adhere to a reduced-calorie diet and achieve weight loss goals.

Qsymia is typically prescribed as part of a comprehensive weight loss program that includes dietary modifications and increased physical activity. It is indicated for long-term use, but its safety and effectiveness over periods longer than two years have not been established.

Due to its potential side effects and risks, Qsymia should only be used under the supervision of a healthcare professional and is typically recommended for individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with weight-related comorbidities.

Contrave is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults who are overweight or obese. It is a combination medication containing two active ingredients: bupropion hydrochloride and naltrexone hydrochloride.

Bupropion is an antidepressant medication that is also used to aid in smoking cessation. It works by affecting the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine, which are involved in regulating mood and appetite.

Naltrexone is a medication primarily used to treat alcohol dependence and opioid addiction. It works by blocking the effects of opioid drugs and alcohol in the brain, thereby reducing cravings.

The combination of bupropion and naltrexone in Contrave is thought to work synergistically to help control appetite and food cravings, leading to reduced caloric intake and weight loss.

Contrave is typically prescribed as part of a comprehensive weight loss program that includes dietary modifications and increased physical activity. It is indicated for long-term use, but its safety and effectiveness over periods longer than one year have not been established.

Due to its potential side effects and risks, Contrave should only be used under the supervision of a healthcare professional and is typically recommended for individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with weight-related comorbidities.

Orlistat is a medication used to aid in weight loss by preventing the absorption of dietary fats in the digestive system. It belongs to a class of drugs called lipase inhibitors. Orlistat works by inhibiting the activity of pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. By blocking the action of this enzyme, Orlistat prevents the absorption of some of the fats consumed in the diet, leading to reduced calorie intake and subsequent weight loss.

Orlistat is typically prescribed as part of a comprehensive weight loss program that includes dietary modifications, exercise, and behavioral therapy. It is intended for use in adults who are overweight or obese and have not been able to lose weight through diet and exercise alone.

Orlistat is available in both prescription strength and over-the-counter formulations. The prescription strength version is sold under the brand name Xenical, while the over-the-counter version is sold under the brand name Alli.

As with any medication, Orlistat may not be suitable for everyone and can have interactions with other medications. It should only be used under the guidance of a healthcare professional. Additionally, Orlistat is not recommended for pregnant or breastfeeding women, individuals with certain gastrointestinal conditions, or those with a history of kidney stones.